Organogenesis Holdings (ORGO) Operating Income Growth (3y) (2019 - 2026)
Organogenesis Holdings (ORGO) Operating Income Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.96 Bn | 32.22 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.55 Bn | 30.61 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 40.17% |
| 10 | Organogenesis Holdings | 327.80 Mn | 235.70 Mn | 11.46 Mn | -158.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -158.22% |
| Dec 31, 2025 | 93.63% |
| Sep 30, 2025 | 126.70% |
| Jun 30, 2025 | -45.08% |
| Mar 31, 2025 | -493.40% |
| Dec 31, 2024 | -19.72% |
| Sep 30, 2024 | -27.33% |
| Jun 30, 2024 | -37.31% |
| Mar 31, 2024 | -32.10% |
| Dec 31, 2023 | -27.21% |
| Sep 30, 2023 | -29.32% |
| Jun 30, 2023 | 84.96% |
| Mar 31, 2023 | 35.75% |
| Dec 31, 2022 | 82.28% |
| Sep 30, 2022 | 30.36% |
| Jun 30, 2022 | 53.70% |
| Mar 31, 2022 | 78.06% |
| Dec 31, 2021 | 85.75% |
| Sep 30, 2021 | 53.48% |
| Jun 30, 2021 | 50.15% |